20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9673 | RET-IN-3 | c-RET | |
RET-IN-3 is a RETV804M kinase inhibitor with potential anticancer activity for the study of non-small cell lung cancer. | |||
T8467 | RET V804M-IN-1 | RETV804M kinase inhibitor,LUN09945 | c-RET |
RET V804M-IN-1 (RETV804M kinase inhibitor) is a wt-RET -selective RETV804M kinase inhibitors(IC50 = 20 nM). | |||
T40097 | RET-IN-4 | ||
RET-IN-4 is a highly effective and specific RET inhibitor that can be administered orally. It demonstrates remarkable potency, with IC50 values of 1.29 nM, 1.97 nM, and 0.99 nM for inhibiting RET variants including RET (... | |||
T69644 | DUN73423 | RET-IN-21 | c-RET |
DUN73423 (RET-IN-21) is a potent tyrosine kinase (RET) inhibitor with antitumour activity for the study of cancer. | |||
T16735 | RET-IN-1 | Others | |
RET-IN-1 is a RET kinase inhibitor (IC50s: 1 nM, 7 nM, and 101 nM for RET (WT), RET (V804M) , and RET (G810R), respectively). | |||
T63772 | RET-IN-5 | ||
RET-IN-5 is a potent inhibitor of RET (IC50: 4.57 nM). | |||
T63877 | RET-IN-17 | ||
RET-IN-17 is a potent inhibitor of RET. RET-IN-17 has potential for studies of pain associated with IBS and other gastrointestinal disorders, as well as cancers with constitutive RET kinase activity. | |||
T79163 | RET-IN-24 | ||
RET-IN-24 (Compound 26) is a selective inhibitor of RET tyrosine kinase, demonstrating antitumor activity [1]. | |||
T78683 | RET-IN-22 | ||
RET-IN-22 (compound 17b) is a potent, selective, and orally active inhibitor of RET, exhibiting IC50 values of 20.9 nM for wild-type RET and 18.3 nM for RET-V804M. It demonstrates a highly selective inhibition profile ac... | |||
T63358 | RET-IN-15 | ||
RET-IN-15 is an inhibitor of rearrangement kinase (RET) during transfection and can be used in cancer research. | |||
T73256 | RET-IN-16 | ||
RET-IN-16 is a potent, selective inhibitor of RET, exhibiting IC50 values of 3.98 nM for RET(WT), 8.42 nM for RET(M918T), 15.05 nM for RET(V804L), 7.86 nM for RET(V804M), 5.43 nM for RET-CCDC6, and 8.86 nM for RET-KIF5B,... | |||
T63249 | RET-IN-6 | ||
RET-IN-6 is a potent inhibitor of RET (IC50: 4.57 nM). | |||
T63583 | RET-IN-11 | ||
RET-IN-11 is a potent and selective RET inhibitor that acts on RET (IC50: 6.20 nM) and RETV804M (IC50: 18.68 nM).RET-IN-11 induces apoptosis.RET-IN-11 exhibits anti-proliferative and migratory effects in LC-2/ad cells. R... | |||
T62877 | RET-IN-7 | ||
RET-IN-7 exhibits strong inhibitory effects against RET kinase in vitro and shows significant efficacy in treating RET-driven tumor xenografts in mice through multiple-day dosing. | |||
T81296 | RET-IN-26 | ||
RET-IN-26 (compound D5) is a kinase inhibitor that selectively targets the RET protein with an IC50 value of 0.33 μM [1]. | |||
T63183 | RET-IN-9 | ||
RET-IN-9 is a potent inhibitor of RET. RET kinase is a single-channel transmembrane receptor tyrosine kinase that plays an important role in the development of the kidney and enteric nervous system, as well as in the mai... | |||
T64103 | RET-IN-12 | ||
RET-IN-12 is a RET inhibitor capable of acting on RET(WT) (IC50: 0.3 nM) and RET(V804M) (IC50: 1 nM). | |||
T79099 | RET-IN-23 | ||
RET-IN-23 (compound 17) is a potent, orally active inhibitor of RET, displaying IC50 values of 1.32 nM for RET-WT, 2.50 nM for RET-CCDC6, 6.54 nM for RET-V804L, 1.03 nM for RET-V804M, and 1.47 nM for RET-M918T. The compo... | |||
T63468 | RET-IN-14 | ||
RET-IN-14 is a potent inhibitor of RET, capable of acting on RET (WT) (IC50 < 0.51 nM), RET (G810R) (IC50: 9.3 nM), RET (V804M) (IC50: 1.3 nM), BTK (C481S) (IC50: 9.2 nM) and BTK (C481S) (IC50 : 15 nM). RET-IN-14 exhibit... | |||
T63837 | RET-IN-19 | ||
RET-IN-19 is a potent inhibitor of RET and exhibits anticancer effects on RET-wt (IC50: 6.8 nM) and RET V804M (IC50: 13.51 nM).RET-IN-19 can be used to study non-small cell lung cancer (NSCLC). |